MattsonJack Europe Appoints Business Head

Kantar-owned pharma and biotech research consultancy MattsonJack has appointed Dr Pierre Anhoury as Senior Vice President and Business Leader, to support the expansion of the firm's cancer and non-cancer qual and quant services in Europe.

Anhoury most recently worked at IMS Global Consulting in Paris, where as Director of Pricing and Market Access, he supported strategic planning for most of the university hospitals dedicated to cancer treatment in France, and worked as a consultant for a number of oncology-specific projects. Prior to this, he spent 16 years in healthcare consulting with Deloitte & Touche and Ernst & Young. He is a physician by training, with a speciality in public health and health economics, having completed a Master's in Public Health from Nancy University in France and a Master's in Risk Management from University Health Sciences in Chicago.

President and COO Richard Martin commented: 'Dr Anhoury will have full responsibility for leadership, management, and growth of our European business unit. His education, experience, and market insight add tremendous value in addressing our clients' needs.'

Anhoury regularly delivers courses and conferences in Europe and Canada and has been a BioVision rapporteur since 1999.

The firm offers commercial and scientific expertise, as well as market modeling and forecasting, and primary market research from its offices in Philadelphia, St Louis, San Francisco, Kansas City, Phoenix, Paris, London and Tokyo. It is online at www.mattsonjack.com.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Mattson Jack Group (MJG)
• All news